| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 1.667 | 24.158 | 18.003 | 25.656 | 24.566 | 30.017 | 39.153 |
| Total Income - EUR | - | - | - | 1.667 | 24.572 | 18.172 | 25.912 | 24.569 | 43.069 | 39.388 |
| Total Expenses - EUR | - | - | - | 671 | 14.415 | 12.871 | 23.174 | 37.032 | 41.340 | 37.315 |
| Gross Profit/Loss - EUR | - | - | - | 997 | 10.157 | 5.301 | 2.738 | -12.463 | 1.729 | 2.073 |
| Net Profit/Loss - EUR | - | - | - | 947 | 9.425 | 4.790 | 2.025 | -13.112 | 183 | 1.357 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dr. Mărăzan S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 66 | 42 | 18.525 | 13.816 | 7.948 | 36.249 | 33.587 |
| Current Assets | - | - | - | 1.520 | 9.614 | 3.855 | 7.221 | 4.981 | 1.819 | 2.199 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 136 | 199 | 0 | 72 | 286 | 141 | 139 |
| Cash | - | - | - | 1.384 | 9.415 | 3.855 | 7.149 | 4.695 | 1.679 | 2.059 |
| Shareholders Funds | - | - | - | 990 | 9.437 | 13.992 | 15.707 | 2.644 | 2.705 | 3.877 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 597 | 3.653 | 14.241 | 11.309 | 15.390 | 40.650 | 37.167 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr. Mărăzan S.r.l.